|
Volumn 91, Issue 2, 1995, Pages 541-548
|
Gene therapy for cardiovascular disease
|
Author keywords
cardiovascular diseases; genes; myocardium
|
Indexed keywords
ALTEPLASE;
ANGIOTENSIN;
APOLIPOPROTEIN A1;
ATRIAL NATRIURETIC FACTOR;
CAPSID PROTEIN;
CHLORAMPHENICOL ACETYLTRANSFERASE;
CHOLESTEROL;
CHYLOMICRON;
CYTOKINE;
DNA;
GANCICLOVIR;
GENE PRODUCT;
GROWTH FACTOR;
HIGH DENSITY LIPOPROTEIN;
LIPOSOME;
LOW DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN RECEPTOR;
MESSENGER RNA;
MYOSIN HEAVY CHAIN;
NITRIC OXIDE SYNTHASE;
NUCLEIC ACID;
PLASMID DNA;
POLYLYSINE;
POLYMER;
THYMIDINE KINASE;
TRANSFERRIN;
UNINDEXED DRUG;
VASCULAR CELL ADHESION MOLECULE 1;
VIRUS DNA;
VIRUS PROTEIN;
VIRUS VECTOR;
ADENOVIRUS;
ARTICLE;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CYTOTOXIC T LYMPHOCYTE;
GENE;
GENE EXPRESSION;
GENE TARGETING;
GENE THERAPY;
GENE TRANSFER;
HEART MUSCLE CELL;
HUMAN;
HYDROGEL;
IMMUNE RESPONSE;
LIPOPROTEIN METABOLISM;
NONHUMAN;
PARAINFLUENZA VIRUS 1;
PRIORITY JOURNAL;
RECOMBINANT DNA TECHNOLOGY;
RETROVIRUS;
|
EID: 0028883249
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.cir.91.2.541 Document Type: Article |
Times cited : (176)
|
References (0)
|